Marathon Capital Management Pfizer Inc Transaction History

Marathon Capital Management

$399 Million
Q3 2024

A detailed history of Marathon Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Marathon Capital Management holds 105,838 shares of PFE stock, worth $2.79 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

105,838

Previous 105,439 0.38%

Holding current value

$2.79 Million

Previous $2.95 Million 3.8%

% of portfolio

0.77%

Previous 0.78%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $11,052 - $12,524	399 Added 0.38%	105,838 $3.06 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $3,005 - $3,522	119 Added 0.11%	105,439 $2.95 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $23,456 - $26,935	906 Added 0.87%	105,320 $2.92 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $1.24 Million - $1.61 Million	-47,482 Reduced 31.26%	104,414 $3.01 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $64,629 - $75,545	2,014 Added 1.34%	151,896 $5.04 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $56,383 - $65,234	1,561 Added 1.05%	149,882 $5.5 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $3.75 Million - $4.88 Million	95,186 Added 179.14%	148,321 $6.05 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $61,706 - $80,551	1,478 Added 2.86%	53,135 $2.72 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.78 Million - $2.18 Million	40,724 Added 372.49%	51,657 $2.26 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $5,032 - $6,235	110 Added 1.02%	10,933 $566,000
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $209,161 - $310,047	-5,062 Reduced 31.87%	10,823 $643,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $160,257 - $205,864	4,083 Added 34.6%	15,885 $684,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $59,969 - $67,935	1,670 Added 16.48%	11,802 $462,000
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $30,174 - $34,030	901 Added 9.76%	10,132 $367,000
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $27,211 - $34,601	813 Added 9.66%	9,231 $339,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $15,906 - $18,662	501 Added 6.33%	8,418 $308,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $27 - $38	1 Added 0.01%	7,917 $258,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $260,594 - $295,741	7,916 New	7,916 $310,000
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $353,426 - $458,290	-10,878 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$36.98 - $41.52 $1,848 - $2,076	50 Added 0.46%	10,878 $471,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $937 - $1,030	25 Added 0.23%	10,828 $459,000
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $4,347 - $4,956	-113 Reduced 1.04%	10,803 $471,000
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $29,714 - $31,679	-901 Reduced 7.62%	10,916 $396,000
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $19,848 - $23,026	622 Added 5.56%	11,817 $419,000
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $87,340 - $92,671	2,626 Added 30.65%	11,195 $405,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $265,639 - $292,631	8,569	8,569 $306,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.

Account

Marathon Capital Management Pfizer Inc Transaction History